Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Parkinson: early-phase trial registry
5 of 6 indexed Parkinson trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Parkinson: 6 US clinical trials tracked, 5 recruiting.
Parkinson is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is CND Life Sciences, running 2 of these trials.
Enrollment posture brief
Registry condition parkinson
OPEN 5 | RECR 83% | LATE 0 | EARLY 1 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)
Parkinson lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Parkinson on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Parkinson is recruiting above its size-band peers.
5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Parkinson research.
CND Life Sciences accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Parkinson trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.
-
Parkinson research leans observational.
1 interventional and 5 observational studies make up this index (16.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Neuron23
NCT06680830
Studies of Brain and Body Interaction
Rutgers University
NCT03672266
Neuroplasticity in Parkinson's Disease
University of Minnesota
NCT05286736
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
CND Life Sciences
NCT07217054
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
CND Life Sciences
NCT07204652
Effects of Deep Brain Stimulation for the Treatment of Parkinson's Disease
US Department of Veterans Affairs
NCT00358189
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Parkinson records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Parkinson trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Parkinson page
6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Parkinson trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- CND Life Sciences sponsors the most Parkinson trials on record, review their full trial history before evaluating a specific study. See CND Life Sciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Parkinson condition card totals 6 registered trials; most-linked intervention NEU-411; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.